Hydrocortisone and Acetic Acid description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Hydrocortisone and Acetic Acid

Qualitest Pharmaceuticals

HYDROCORTISONE AND ACETIC ACID OTIC SOLUTION, USP


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

HYDROCORTISONE AND ACETIC ACID DESCRIPTION

Hydrocortisone and Acetic Acid Otic Solution, USP is a solution containing hydrocortisone (1%) and acetic acid (2%), in a propylene glycol vehicle containing propylene glycol diacetate (3%), benzethonium chloride (0.02%), sodium acetate (0.015%) and citric acid. The empirical formulas for acetic acid and hydrocortisone are CH3COOH and C21H30O5, with a molecular weight of 60.05 and 362.46, respectively. The structural formulas are:

Hydrocortisone and Acetic Acid

Hydrocortisone and Acetic Acid Otic Solution is available as a nonaqueous otic solution buffered at pH 3 for use in the external ear canal.

CLINICAL PHARMACOLOGY

Acetic acid is antibacterial and antifungal; hydrocortisone is anti-inflammatory, antiallergic and antipruritic; propylene glycol is hydrophilic and provides a low surface tension; benzethonium chloride is a surface active agent that promotes contact of the solution with tissues.

HYDROCORTISONE AND ACETIC ACID INDICATIONS AND USAGE

For the treatment of superficial infections of the external auditory canal caused by organisms susceptible to the action of the antimicrobial, complicated by inflammation.

HYDROCORTISONE AND ACETIC ACID CONTRAINDICATIONS

Hypersensitivity to Hydrocortisone and Acetic Acid Otic Solution or any of the ingredients; herpes simplex, vaccinia and varicella. Perforated tympanic membrane is considered a contraindication to the use of any medication in the external ear canal.

WARNINGS

Discontinue promptly if sensitization or irritation occurs.

PRECAUTIONS

Transient stinging or burning may be noted occasionally when the solution is first instilled into the acutely inflamed ear.

PEDIATRIC USE

Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

HYDROCORTISONE AND ACETIC ACID ADVERSE REACTIONS

Stinging or burning may be noted occasionally; local irritation has occurred very rarely.

HYDROCORTISONE AND ACETIC ACID DOSAGE AND ADMINISTRATION

Carefully remove all cerumen and debris to allow Hydrocortisone and Acetic Acid Otic Solution to contact infected surfaces directly. To promote continuous contact, insert a wick of cotton saturated with Hydrocortisone and Acetic Acid Otic Solution into the ear canal; the wick may also be saturated after insertion. Instruct the patient to keep the wick in for at least 24 hours and to keep it moist by adding 3 to 5 drops of Hydrocortisone and Acetic Acid Otic Solution every 4 to 6 hours. The wick may be removed after 24 hours but the patient should continue to instill 5 drops of Hydrocortisone and Acetic Acid Otic Solution 3 or 4 times daily thereafter, for as long as indicated. In pediatric patients, 3 to 4 drops may be sufficient due to the smaller capacity of the ear canal.

HOW SUPPLIED

Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone (1%) and acetic acid (2%), is available in 10 mL, measured-drop, safety-tip plastic bottles.

STORAGE

Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature]. Keep container tightly closed.

Manufactured for:
QUALITEST PHARMACEUTICALS
Huntsville, AL 35811

8180670
R11/07-R1

PRINCIPAL DISPLAY PANEL

Hydrocortisone and Acetic Acid

Hydrocortisone and Acetic Acid

hydrocortisone and acetic acid SOLUTION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:0603-7039
Route of Administration AURICULAR (OTIC) DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
ACETIC ACID 0.02 mL
Hydrocortisone HYDROCORTISONE 0.01 mL

Inactive Ingredients

Ingredient Name Strength
PROPYLENE GLYCOL DIACETATE
benzethonium chloride
SODIUM ACETATE
Citric acid

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0603-7039-39 10 in 1 BOTTLE, DROPPER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA040609 2006-02-06


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.